Vascular Diseases  >>  Decadron (dexamethasone)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

7 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Decadron (dexamethasone) / Merck (MSD)
NCT00002548: SWOG-9321 Melphalan, TBI, and Transplant vs Combo Chemo in Untreated Myeloma

Completed
3
899
US
recombinant interferon alfa, IFN, alpha interferon, carmustine, BCNU, cyclophosphamide, cytoxan, dexamethasone, steroid, decadron, doxorubicin hydrochloride, Adriamycin, melphalan, prednisone, vincristine sulfate, allogeneic bone marrow transplantation, autologous bone marrow transplantation, peripheral blood stem cell transplantation, radiation therapy
Southwest Oncology Group, National Cancer Institute (NCI), Cancer and Leukemia Group B, Eastern Cooperative Oncology Group
Multiple Myeloma
10/03
11/06
NCT00056160: CC-5013 Plus Dexamethasone Versus Dexamethasone Alone in Previously Treated Subjects With Multiple Myeloma

Completed
3
353
US, Canada
CC-5013, lenalidomide, Revlimid, Dexamethasone, Decadron
Celgene
Multiple Myeloma
11/05
10/08
NCT01296503: Thalidomide Plus Dexamethasone as Maintenance Therapy for Multiple Myeloma

Completed
3
213
RoW
Thalidomide plus dexamethasone, Thalomid, Baycadron, DexPak, Decadron, Dexamethasone
Grupo de Estudos Multicentricos em Onco-Hematologia
Multiple Myeloma
07/08
12/10
NCT00179647: Expanded Access Program:Lenalidomide With or Without Dexamethasone In Previously Treated Subjects With Multiple Myeloma

Completed
3
1913
US, Canada
lenalidomide, Revlimid, dexamethasone, Decadron
Celgene Corporation, Prologue Research International
Multiple Myeloma
12/08
04/09
NCT00083915: DTPACE Followed by Tandem Transplant With Melphalan (MEL) 200 Versus MEL/Dexamethasone/Thalidomide (DT) Platinol/Adriamycin/Etoposide (PACE) Hybrid and DTPACE Consolidation

Completed
3
97
US
Cisplatin, Cisplatinum, cis-diamminedichloroplatinum, Platinol, Platinol-injectable (AQ), Cyclophosphamide, Endoxan, Cytoxan, Neosar, Procytox, Revimmune, Adriamycin, hydroxydaunorubicin, Doxorubicin, Etoposide, Eposin, Etopophos, Vepesid, Melphalan, alkeran, Thalidomide, Thalomid, Dexamethasone, Decadron
University of Arkansas
Multiple Myeloma
06/10
06/10
NCT00215943: Phase III Randomized Trial of Thalidomide/Dexamethasone Versus Vincristine+Adriamycin+Dexamethasone (VAD)

Terminated
3
90
US
zoledronic acid, Zometa®, Zoledronate, dexamethasone, Decadron, NSC-34521, thalidomide, Thalomid™, vincristine, Oncovin, NSC-67574, adriamycin, Doxorubicin, NSC-123127
H. Lee Moffitt Cancer Center and Research Institute, Novartis
Multiple Myeloma
08/12
08/12
NCT00038090: Thalidomide-Dexamethasone for Multiple Myeloma

Completed
2/3
83
US
Thalidomide, Thalomid, Dexamethasone, Decadron
M.D. Anderson Cancer Center, Celgene Corporation
Multiple Myeloma
05/05
05/05

Download Options